Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Matej Pe%C4%8Dovnik) .

71 - 80 / 166
First pagePrevious page45678910111213Next pageLast page
71.
Pristine and ruthenium-doped ▫$TiO_2$▫ nanoclusters for nitrogen reduction reaction : Ab initio study of structure and adsorption
Taja Žibert, Blaž Likozar, Matej Huš, 2023, original scientific article

Published in DiRROS: 22.11.2022; Views: 556; Downloads: 389
.pdf Full text (1,83 MB)
This document has many files! More...

72.
Multiscale study of functional acetylation of cellulose nanomaterials by design : Ab initio mechanisms and chemical reaction microkinetics
Ana Oberlintner, Matej Huš, Blaž Likozar, Uroš Novak, 2022, original scientific article

Published in DiRROS: 21.11.2022; Views: 432; Downloads: 243
.pdf Full text (10,68 MB)
This document has many files! More...

73.
The primary and secondary mineral resources of Montenegro and their mapping into the European data model
Slobodan Radusinović, Robert Šajn, Božica Jovanović, Duška Rokavec, Katarina Hribernik, Vasilije Abramović, Matej Draksler, Ivan Danilović, Mia Jovanović, 2022, original scientific article

Abstract: Primary and secondary mineral resources are of strategic importance to the EU economy. Montenegro, as a country candidate for membership in the EU, is required to follow (and later to implement) European policies, strategies as well as initiatives, including those related to mineral resources and the mining sector. The importance of providing access to mineral raw materials in the future is recognized by the EU, as well as meeting the needs of European industry, maintaining employment and ensuring further development. Considering the overall economic situation in Montenegro, it is important to encourge the mining sector and other industries based on the use of mineral resources in making a greater contribution to the development and sustainability of society as a whole and also increase the share of national GDP. The potential for discovery and utilization of primary and secondary mineral resources in Montenegro is demonstrated. The most important metallic mineral resources are bauxite, lead and zinc, while conventional energy resources include coal (oil and gas potential has yet to be proven). In addition, there are abundant non-metallic mineral raw materials - industrial minerals and construction materials. Secondary mineral resources, especially aluminous red mud (bauxite residue), are also significant and have been the subject of research in recent years. Tailings from flotation processes at operating and abandoned lead and zinc mines might also be of interest for metal recovery. Bottom and flay ash from thermal power plants, slag from steel production, as well as marlstone and limestone from the hanging wall of coal deposits may also have potential. Waste rocks could be used particularly for secondary aggregate production. A database was developed and the most important deposits of primary and secondary mineral resources in Montenegro were mapped during the RESEERVE project. Mineral data were harmonised so as to be INSPIRE compliant. In addition, some novel geochemical exploration results of secondary mineral resources are presented.
Keywords: primary and secondary mineral resources, Montenegro, RESEERVE project, European geological data platform (EGDI), INSPIRE
Published in DiRROS: 16.11.2022; Views: 483; Downloads: 183
.pdf Full text (8,52 MB)

74.
75.
Electronic properties of rutile and anatase ▫$TiO_2$▫ and their effect on ▫$CO_2$▫ adsorption : a comparison of first principle approaches
Žan Kovačič, Blaž Likozar, Matej Huš, 2022, original scientific article

Published in DiRROS: 10.08.2022; Views: 595; Downloads: 145
.pdf Full text (3,01 MB)
This document has many files! More...

76.
Dissipative particle dynamics simulation of ultrasound propagation through liquid water
Petra Papež, Matej Praprotnik, 2022, original scientific article

Published in DiRROS: 10.08.2022; Views: 545; Downloads: 287
.pdf Full text (3,98 MB)
This document has many files! More...

77.
Microkinetic modelling of heterogeneous catalysis revisited : adsorption energies can triumph over activation barriers
Luka Skubic, Drejc Kopač, Blaž Likozar, Matej Huš, 2022, original scientific article

Published in DiRROS: 14.07.2022; Views: 665; Downloads: 124
.pdf Full text (1,84 MB)
This document has many files! More...

78.
Genska terapija v onkologiji, prvi razvojni koraki v Sloveniji
Maja Čemažar, Tanja Jesenko, Maša Omerzel, Boštjan Markelc, Urška Kamenšek, Simona Kranjc Brezar, Špela Kos, Urša Lampreht Tratar, Katarina Žnidar, Andrej Renčelj, Urška Matkovič, Teja Valant, Kristina Levpušček, Živa Modic, Tilen Komel, Tim Božič, Urša Kešar, Barbara Starešinič, Katja Uršič Valentinuzzi, Monika Savarin, Primož Strojan, Gorana Gašljević, Maja Ota, Aleš Grošelj, Črt Jamšek, Rosana Hudej, Matjaž Peterka, Franc Smrekar, Barbara Hubad, Marjan Hosta, Jaka Kužnik, Alojz Hosta, Damijan Miklavčič, Matej Reberšek, Aleksandra Cvetkoska, Anja Zajc, Janja Dermol-Černe, Nataša Tozon, Nina Milevoj, Alenka Nemec Svete, Gregor Serša, 2022, professional article

Abstract: Genska terapija postaja čedalje bolj zanimiva tudi v onkologiji. Med aplikacijami je morda najzanimivejša imunostimulacija. Pripravimo lahko plazmidno DNA, ki nosi zapis za različne imunostimulatorne molekule, ki jih vnesemo v celice tumorjev ali normalnih tkiv. Ta tkiva postanejo proizvajalci teh molekul, ki lahko delujejo lokalno ali pa se izločajo tudi sistemsko v krvni obtok. Ker plazmidna DNA ne prehaja celične membrane, so potrebni dostavni sistemi, virusni ali nevirusni. V naših študijah uporabljamo predvsem nevirusni dostavni sistem – elektroporacijo. Interlevkin 12 (IL-12) je eden od zanimivih citokinov, za katerega je znano protitumorsko delovanje s spodbujanjem imunskega odziva in antiangiogenim delovanjem. Namen projekta SmartGene.si je bil pripraviti plazmid z zapisom za interlevkin 12 (plazmid phIL12) in pripraviti vse potrebno za njegovo klinično testiranje za zdravljenje kožnih tumorjev. V konzorciju smo združili moči s partnerji z akademskega in industrijskega področja. Treba je bilo pripraviti plazmid za uporabo v humani onkologiji po zahtevah Evropske agencije za zdravila (EMA). Za prijavo klinične študije na Javno agencijo za zdravila in medicinske pripomočke (JAZMP) smo morali izvesti tudi vse neklinične raziskave o varnosti in učinkovitosti zdravila. Nato je bilo treba razviti postopek priprave zdravila, zagotoviti primerne prostore za pripravo in izvedbo postopka priprave zdravila. V treh letih smo dosegli vse te zastavljene cilje in dobili dovoljenje za izvajanje klinične študije na kožnih tumorjih, ki ga je izdala JAZMP na osnovi pozitivnega mnenja Komisije Republike Slovenije za medicinsko etiko. Zdaj poteka klinična študija faze I preizkušanja plazmida phIL12 na kožnih tumorjih glave in vratu z namenom preveriti varnost in sprejemljivost genskega elektroprenosa plazmida v tumorje. Cilj študije je prav tako določiti primeren odmerek zdravila, ki bi ga v nadaljnji klinični študiji uporabili kot adjuvantno zdravljenje k ablativnim terapijam, kot sta radioterapija ali elektrokemoterapija.
Keywords: genska terapija, interlevkin-12, plazmidna DNA, elektroprenos genov, rak kože
Published in DiRROS: 01.07.2022; Views: 1322; Downloads: 268
.pdf Full text (420,40 KB)

79.
80.
Search done in 0.35 sec.
Back to top